December 5-6th, 2018

Boston, MA

Paragon Bioservices


Working as an outsourcing partner, and with a long-standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and academic laboratories involved in identifying, developing and producing monoclonal antibodies, therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics. Paragon’s focus is the development and manufacturing of biopharmaceutical protein drugs. As a contract development and manufacturing organization (CDMO), Paragon is positioned to capitalize on industry trends—including consolidation in the pharmaceutical industry, all-encompassing “Programmatic Outsourcing”, and the looming imperative that is National Preparedness.